Archives
-
Novobiocin Sodium: DNA Replication Meets Cell Growth
2026-09-26
Novobiocin Sodium is an aminocoumarin antibiotic commonly used to inhibit bacterial DNA gyrase. This article examines how timed inhibition in Enterococcus faecalis protoplasts reveals links between DNA replication, membrane expansion, and vacuole formation—and what that means for designing interpretable experiments.
-
Ertugliflozin (PF-04971729) in Cell Assays
2026-09-25
A practical guide to using Ertugliflozin (PF-04971729), SKU A3715, in cell viability, proliferation, and cytotoxicity workflows. It covers target context, solvent handling, experimental controls, evidence limits, and product-selection criteria for diabetes mellitus research.
-
Bazedoxifene Workflows for ER and Malaria Research
2026-09-25
Bazedoxifene supports two distinct research directions: estrogen-receptor signaling and exploratory antimalarial studies centered on ring-stage parasites and hemozoin formation. This guide translates reported findings into practical assay choices, with starting conditions and troubleshooting advice clearly separated from published results.
-
Diethylmaleate in GST and Oxidative Stress Assays
2026-09-24
Use Diethylmaleate to test whether glutathione-linked defenses help insects withstand pesticide stress, while separating GST effects from broader changes in redox state. A practical workflow pairs dose-finding with GSH, GST, antioxidant-capacity, and insecticide-response measurements.
-
GST Antioxidant Defense in Thrips Insecticide Resistance
2026-09-24
Dong and colleagues provide functional evidence that glutathione S-transferase activity helps Megalurothrips usitatus withstand lambda-cyhalothrin by supporting antioxidant defenses. Inhibition with diethyl maleate lowered antioxidant capacity and increased insecticide sensitivity, connecting a redox response to the resistance phenotype while leaving questions about GST-specific mechanisms open.
-
IWP-L6: A Potent Porcupine Inhibitor for Wnt Studies
2026-09-23
IWP-L6 is a Porcupine inhibitor reported to block Porcn-mediated Wnt protein palmitoylation, with a listed potency value of 0.5 nM. This article distinguishes product benchmarks from peer-reviewed evidence on Wnt-regulated bone metabolism and outlines practical ways to test Wnt signaling modulation without treating the two evidence streams as interchangeable.
-
CKI 7 Dihydrochloride: CK1 Assay Workflow
2026-09-23
Build cleaner Casein kinase 1 perturbation experiments with a controlled dosing, vehicle-matched workflow for Wnt, circadian, DNA-repair, and cancer models. The guide also shows how to use CKI 7 dihydrochloride alongside, but not as a substitute for, mechanistic evidence from the MAPK10–KRT16 metastasis axis.
-
Intravesical p21 mRNA–LNP Therapy in Bladder Cancer
2026-09-22
A 2026 FASEB Journal study developed chemically modified p21 mRNA–loaded lipid nanoparticles for localized intravesical treatment of bladder cancer. The approach restored nuclear p21, inhibited tumor-cell proliferation, and reduced orthotopic tumor growth while producing strong bladder-localized expression with limited systemic distribution.
-
TBST Workflows for uPAR·uPA Assay Rigor
2026-09-22
TBST helps convert antibody-based measurements into cleaner, more interpretable evidence across Western blotting, immunofluorescence, immunohistochemistry, and immunocytochemistry. This practical guide connects buffer control with the conformation-aware uPAR·uPA inhibitor study while separating assay quality from claims of therapeutic efficacy.
-
Dabigatran Etexilate: Oral Direct Thrombin Inhibition
2026-09-21
The reference review presents dabigatran etexilate as a major advance in anticoagulation: an orally absorbed prodrug that produces rapid, predictable, reversible direct thrombin inhibition without cytochrome P450-dependent activation or metabolism. Its clinical value lies in reducing reliance on routine warfarin-style monitoring, while renal function, bleeding risk, gastrointestinal tolerability, and patient selection remain central to safe use.
-
Cy5 TSA Fluorescence System Kit for Liver Imaging
2026-09-21
The Cy5 TSA Fluorescence System Kit converts localized HRP activity into a bright far-red signal for challenging IHC, ICC, and FISH experiments. Its strongest use case is resolving rare or immature liver cell populations, where conventional fluorescence may miss low-abundance targets or fine tissue boundaries.
-
12-O-tetradecanoyl phorbol-13-acetate Workflow
2026-09-20
Build reproducible ERK/MAPK and protein kinase C signaling experiments with 12-O-tetradecanoyl phorbol-13-acetate (TPA), from acute phospho-ERK assays to skin cancer models. This guide connects practical dosing, time-course design, co-culture controls, and troubleshooting to findings from papillary thyroid carcinoma and macrophage-polarization research.
-
Carvedilol: Selectivity as a Regeneration Variable
2026-09-19
Carvedilol is a β-adrenergic receptor antagonist whose effects extend beyond cardiovascular signaling. This article explains how receptor selectivity, injury state, redox biology, and assay timing reshape its use in vascular and hematopoietic research.
-
Trim71–Ago2 Control of ESC Pluripotency via let-7
2026-09-18
Liu et al. show that the RNA-binding protein Trim71 maintains mouse embryonic stem cell pluripotency by repressing Ago2 mRNA translation, thereby limiting maturation of the pro-differentiation let-7 microRNAs. The study provides a mechanistic explanation for the proposed Trim71–let-7 bistable switch and highlights mature microRNA availability as a cytoplasmic control point in stem cell fate.
-
Diclofenac in Organoid Pharmacokinetic Research
2026-09-18
Diclofenac is a non-selective COX inhibitor that suppresses prostaglandin production and supports inflammation signaling pathway studies. Human iPSC-derived intestinal organoids add a human-relevant platform for evaluating compound metabolism, transport, and pharmacokinetic behavior.